| 1/3 | US=94 / Biol/Mol Matthews DJ, Gerritsen ME. Current challenges and future directions. In: ___. Targeting protein kinases for cancer therapy. New Jersey: Wiley, 2010. p. 623-63. ISBN 978-0-470-22965-1. INIBIDORES DA QUINASE; RESISTENCIA A MEDICAMENTOS; BOMBAS DE EFLUXO; TRANSPORTADORES DE DROGAS; FATORES DMPK; MUTACAO; TERAPIA; INIBIDORES DE ANGIOGENESE; QUIMIOTERAPIA; SISTEMA BIOLOGICO; MEDICINA TRANSLACIONAL |
| 2/3 | US=39 / Patologia Futschik ME, Kemmener W, Schafer R, Sers C. The human transcriptome: implications for the understanding of human disease. In: Coleman WB, Tsongalis GJ. Molecular pathology: the molecular basis of human disease. Amsterdam: Elsevier, 2009. p. 123-49. ISBN 978-0-12-374419-7. TRANSCRIPTOMA HUMANO; EXPRESSAO GENICA; MICROARRAYS; MEDICINA TRANSLACIONAL |
| 3/3 | US=69 / Câncer Wheler J, Kurzrock R. Perspectives: bench to bedside and back. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 1-19. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; MEDICINA TRANSLACIONAL; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |